Aviva’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Aviva’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,457	Closed	-$1.23M	–	992
2021 Q1	$1.23M	Buy	+11,457	New	+$1.19M	0.01%	811

Other funds holding NARI

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva's NARI Position: Q2 2021 in Review

Aviva sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2021, closing a stake of 11,457 shares — an estimated $1.23M sold.

Aviva first reported a position in NARI in Q1 2021 and held it in 1 quarter. The position peaked at $1.23M in Q1 2021. 202 funds tracked by Wall St. Rank hold NARI as of Q2 2021.

Aviva reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Aviva sold 11,457 Inari Medical, Inc. Common Stock shares in Q2 2021, an estimated $1.23M.
Aviva first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Aviva's Inari Medical, Inc. Common Stock position peaked at $1.23M in Q1 2021.
202 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.